Mission
In today’s world, we face the threat of pandemics and bioterrorism that pose significant risks to global health security. In an environment where the globalisation of trade accelerates the spread of epidemics and the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations relative to public health and medical emergency.
Fabentech’s mission is to collaborate closely with governments and healthcare organisations, providing timely and effective medical countermeasures to combat highly pathogenic agents during public health crises. We help nations to build robust preparedness plans that enable effective anticipation and response to potential future pandemics and bioterror attacks.
Whether the source is a natural outbreak or a deliberate biological attack, our objective is to minimise the impact of these growing risks and safeguard public health and safety globally.
New realities require a new level of preparedness in Europe. Our citizens, our Member States, and our businesses need the right tools to act both to prevent crises and to react swiftly when a disaster hits.
Ursula von der Leyen – European Commission President (03/2025)
Context
In March 2025, the European Commission published a report on the European Union’s Preparedness Strategy. This strategy aims to enhance both civilian and military preparedness within the EU and strengthen its readiness for future crises, ensuring that all stakeholders are equipped to respond swiftly and effectively when necessary.¹
This European-level preparedness is complemented by national measures implemented in each European country. Within the framework of France’s defense strategy, numerous regulatory texts have been issued to ensure preparedness for biological risks, whether natural or intentional.
For instance, the French biodefense program² aims to enhance the protection of civilian populations and response forces in the event of a biological attack. This preparedness approach is based on two key pillars:
– Epidemiological surveillance and the detection of biological agents in the environment
– Medical protection capabilities, including treatments and vaccines
This program is further reinforced by various guidelines and protocols that define intervention levels and structure France’s response in the event of a health emergency.
Fabentech’s activities align with both French and European ambitions for preparedness against biological risks—including pandemics and bioterrorism—by providing countermeasures tailored to medical protection needs and strengthening the country’s therapeutic arsenal.
To go further:
- – EU Preparedness Union Strategy: EU Preparedness Union Strategy to prevent and react to emerging threats and crises
- – French Participation in european stockpile: Vers une réponse européenne face aux crises NRBC : une contribution française significative – Ministère du Travail, de la Santé, des Solidarités et des Familles
Partnership
Our ongoing projects mark only the starting point of what we aim to achieve. We are open to partnering with individuals or organisations that are ready to tackle issues related to public health and biodefence. Please send us a message if you are interested in a partnership.
Source
¹Article published on March 2025 in the European Commission website : Preparedness – European Commission
²Article published on the France Diplomatie website : Lutte contre les armes biologiques – Ministère de l’Europe et des Affaires étrangères